1. Home
  2. PGEN vs AVNW Comparison

PGEN vs AVNW Comparison

Compare PGEN & AVNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$7.24

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Logo Aviat Networks Inc.

AVNW

Aviat Networks Inc.

HOLD

Current Price

$20.75

Market Cap

278.2M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PGEN
AVNW
Founded
1998
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Radio And Television Broadcasting And Communications Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
278.2M
IPO Year
2013
2007

Fundamental Metrics

Financial Performance
Metric
PGEN
AVNW
Price
$7.24
$20.75
Analyst Decision
Buy
Strong Buy
Analyst Count
5
4
Target Price
$8.33
$34.50
AVG Volume (30 Days)
6.0M
121.8K
Earning Date
05-13-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.03
0.29
Revenue
$230,981,000.00
$243,858,000.00
Revenue This Year
$1,115.92
$5.59
Revenue Next Year
$81.04
$7.03
P/E Ratio
$248.00
$71.41
Revenue Growth
N/A
0.56
52 Week Low
$2.99
$13.92
52 Week High
$7.49
$27.02

Technical Indicators

Market Signals
Indicator
PGEN
AVNW
Relative Strength Index (RSI) 66.39 47.38
Support Level $3.96 $20.60
Resistance Level N/A $22.59
Average True Range (ATR) 0.43 0.86
MACD 0.03 -0.09
Stochastic Oscillator 88.73 15.87

Price Performance

Historical Comparison
PGEN
AVNW

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

About AVNW Aviat Networks Inc.

Aviat Networks Inc provides wireless transport and access networking solutions designed to support telecommunications operators and private network providers situated in various countries. The company offers a range of microwave and millimeter wave radios, network management tools, and services that enable high-capacity, secure, and reliable data transport over wireless networks. Its products serve diverse clients including mobile operators, public safety organizations, utilities, government agencies, and enterprise customers. Aviat generates revenue from the sale of its networking equipment, professional services, and ongoing support contracts. Its operations cover various regions including the Americas, Europe, Asia Pacific, the Middle East, and Africa.

Share on Social Networks: